Search results

Found 398 pages
AUTHOR: George Underwood

Your search yielded no results

  • Check if your spelling is correct.
  • Remove quotes around phrases to search for each word individually. bike shed will often show more results than "bike shed".
  • Consider loosening your query with OR. bike OR shed will often show more results than bike shed.

Bayer halts Xarelto trial

Trial was evaluating the drug in patients with embolic stroke of undetermined source (ESUS). - News - PharmaTimes

by George Underwood

www.pharmatimes.com/news/bayer_halts_xarelto_trial_1207036

Shire and Baxalta near deal

Shire is reportedly in advanced talks to acquire Baxter's biopharma spin-off Baxalta and may announce a deal this week. - News - PharmaTimes

by George Underwood

www.pharmatimes.com/news/shire_and_baxalta_near_deal_1020698

Lansons recruits Kate Aldous

Appointment boosts healthcare offering - Appointments - PharmaTimes

by George Underwood

www.pharmatimes.com/appointments/lansons_recruits_kate_aldous_1029021

Medidata teams with Pharm-Olam

CRO hopes partnership will accelerate drugs' time to market - News - PharmaTimes

by George Underwood

www.pharmatimes.com/news/medidata_teams_with_pharm-olam_1256852

'Universal' flu vaccine to be tested

Vaccine uses T-cells to potentially attack multiple strains of the virus - News - PharmaTimes

by George Underwood

www.pharmatimes.com/news/universal_flu_vaccine_to_be_tested_1206771

Method Medical Media launches

London-based agency begins trading today - News - PharmaTimes

by George Underwood

www.pharmatimes.com/news/method_medical_media_launches_1204334

EC approves Janssen’s Symtuza

Drug is only darunavir-based STR indicated for HIV-1 infection in adults and adolescents - News - PharmaTimes

by George Underwood

www.pharmatimes.com/news/ec_approves_janssens_symtuza_1206421

FDA grants Keytruda priority review

If approved by the FDA, this would mark the third indication for Keytruda in metastatic NSCLC in the United States based on OS data - News - PharmaTimes

by George Underwood

www.pharmatimes.com/news/fda_grants_keytruda_priority_review_1233852

Novartis' biosimilar rituximab delayed in US

Rejection is another win for drugs' originator Roche - News - PharmaTimes

by George Underwood

www.pharmatimes.com/news/novartis_biosimilar_rituximab_delayed_in_us_1234248

Latest jobs

View all

What job are you looking for?

This field is required.

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download